 LexaGene Holdings Inc announced that it has filed and received a receipt for a preliminary short form base shelf prospectus in Canada allowing it to raise up to C25 million. When finalized, the company will be able to make offerings of shares, warrants, subscription receipts, debt securities, units or any combination thereof for up to 25-month period. 